Biomarkers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) have been shown to correlate with systemic inflammation and immune dysfunction, which may play a role in the development of GI side effects [6]. This evidence concerns the gene TNF and immune system disorder.